Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Mary Lynne Hedley, a director at Eli Lilly & Co, acquired shares of common stock through a deferral plan and a trust.

Summary

• Mary Lynne Hedley, a director at Eli Lilly & Co, has reported the acquisition of company stock.
• On November 18, 2024, Ms. Hedley acquired 13,637 shares of common stock at a price of $727.2 per share through a deferral plan.
• These shares were deferred in lieu of cash compensation and will be settled after her separation from service.
• Additionally, Ms. Hedley acquired 302.53 shares of common stock at the same price through a trust.
• Following these transactions, Ms. Hedley directly owns 1,561,592 shares and indirectly owns 1,864,122 shares through the trust.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a director's continued investment in the company, but it is a routine transaction.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
• The use of a deferral plan indicates a long-term commitment to the company.

Future Outlook

The deferred shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It reflects the compensation structure for directors and their investment in the company.

Comparison to Industry Standards

• Director stock acquisitions are a common practice in publicly traded companies, often as part of compensation packages.
• Deferral plans are also a standard method for aligning director interests with long-term company performance.
• The price of $727.2 per share is specific to Eli Lilly's stock at the time of the transaction and would be compared to other pharmaceutical companies' stock prices and director compensation packages.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it shows director confidence in the company.
• The transaction does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Eli Lilly, Director, Stock Acquisition, Deferral Plan, Beneficial Ownership, Common Stock, Trust